Photo taken from Laurie Fenton Ambrose/LinkedIn
May 19, 2024, 10:49
Laurie Fenton Ambrose explains breakthrough advance in extensive-stage small cell lung cancer – Amgen Oncology
Amgen Oncology shared on LinkedIn:
“A breakthrough advance in extensive-stage small cell lung cancer (ES-SCLC) care is here.
Amgen’s immunotherapy is uniquely tailored to people with ES-SCLC, explains Laurie Fenton Ambrose of GO2 for Lung Cancer.
This innovative treatment works by empowering a patient’s own immune system to seek out and help destroy SCLC cells.”
Additional information.
Link to video attached to the post.
Source: Amgen Oncology/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19